Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease
Keywords: ACS; acute coronary syndromes; aPTT; activated partial thromboplastin time; Asp189; aspartic acid residue; CAD; coronary artery disease; EDTA; ethylenediaminetetraacetic acid; EPR-1; effector cell protease receptor-1; F; factor; F1.2; fragment 1.2; FEU; f